In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/05/unclean-hands-accusations-in-south.html In 2018, Bayer Intellectual Property GmbH (“Bayer’) geared up for a battle against Villa Crop Protection (Pty) Ltd (“Villa Crop’) in the South African Patent Court. Bayer alleges that Villa Crop infringes its South African patent, ZA 2005/00230 (the 2005 patent). The 2005 patent claims spirotetramat, as an active... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/05/new-bgh-ruling-to-harmonize-frand-case.html About to enter a new FRAND-era? Time will tel! A six- year long legal dispute between Sisvel and Haier, concerning the question of injunctive relief for infringement of cellular Standard Essential Patents (SEPs) EP 0 852 885 (“885”), owned by Sisvel, has been brought to an end by the... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/05/guest-post-revocations-special.html Covid-19 has without a doubt initiated a new IP saga. What is the impact of IP on the Covid-19 crisis? And how well do relevant exceptions in the patent system, such as compulsory licenses really work in such extraordinary circumstances? IPKat friends Dr. Victor Vaibhav Tandon and Dr. Akanksha... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/05/guest-post-austrias-highest-civil-court.html The IPKat has received news from former GuestKat Mirko Brüß of an interesting Austrian decision tackling the scope of intermediary injunctions. Here’s what Mirko writes: Austria’s highest civil court applies CJEU Glawischnig-Piesczek ruling and orders Facebook to delete content country-wide by Mirko Brüß Readers of this blog will remember the... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/05/around-ip-blogs_10.html Here comes your one-stop shop in the exciting world of the IP blogosphere! An optimistic cat Patents Following the EPO and the UKIPO, the USPTO has also rejected the DABUS application for a patent [the IPKat reported on the EPO’s refusal to grant a patent to an AI-inventor here].... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/05/italian-supreme-court-applies-cjeu.html A KIKO store A couple of years ago, The IPKat reported on the interesting decision of the Court of Appeal of Milan in a case concerning, inter alia, copyright protection of makeup producer and retailer KIKO‘s store layout under Italian law. The ruling, which upheld the decision at first... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/05/never-too-late-if-you-missed-ipkat-last_8.html It is Friday! Sit back, relax and catch up on last week’s news! PATENTS COVID-19 calls for certain patent exceptions, especially when it comes to manufacturing of respiratory equipment parts. An Italian hospital requested a local producer to make valves with 3D printers without authorization of the patent holders. Kat friend Carlo... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/05/the-bad-spaniel-gets-treat-vip-products.html My own “Bad Spaniels” were good enoughto share this chair for a picture…and they got a treat for it! Sometimes, even a bad dog is good enough to get a treat. In 2018, VIP Products – the makers of several dog toys resembling well-known beverage bottles with dog themes... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/05/does-duration-of-storage-matter-live.html At a time when physical proximity is strongly discouraged or prohibited tout court through various measures – ranging from ‘social distancing’ to ‘self-isolation’, from ‘quarantine’ up to strictly enforced ‘lockdowns’ – people have been discovering new or enhancing further the ways through which they connect at a distance, including... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2020/05/guestpost-australian-government-fails.html The AusKat won’t be restrained fromlaunching to attack that wrinkle on thesheets….. In a long-awaited judgment that will affect applications in Australia for interlocutory injunctions to restrain launch of pharmaceutical products, as well as claims for compensation following wrongful exclusion of generic or biosimilar pharmaceuticals from the market, the... Continue reading
Designed by Industrial Action
Copyright © 2026 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION